Tonix Pharmaceuticals Holding Corp (TNXP)
R&D Expenses
$63.86M
TTM · Period ending: · USD
TNXP R&D Expenses
Latest reported$63.86Mperiod ending
Latest reported$63.86Mperiod ending
TNXP TTM R&D Expenses ($0.00 → $63.86M)
TTM R&D Expenses
High-resolution chart · PNG
TNXP r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 63,860,000 | |
| 55,263,000 | |
| 44,486,000 | |
| 35,842,000 | |
| 35,667,000 | |
| 34,545,000 | |
| 39,972,000 | |
| 48,795,000 | |
| 60,731,000 | |
| 73,009,000 | |
| 86,657,000 | |
| 94,211,000 | |
| 95,362,000 | |
| 89,965,000 | |
| 81,876,000 | |
| 79,498,000 | |
| 70,379,000 | |
| 71,933,000 | |
| 68,838,000 | |
| 58,639,000 | |
| 54,370,000 | |
| 46,808,000 | |
| 36,157,000 | |
| 29,750,000 | |
| 25,989,000 | |
| 18,972,000 | |
| 18,192,000 | |
| 17,559,000 | |
| 15,771,000 | |
| 16,284,000 | |
| 17,558,000 | |
| 16,135,000 | |
| 16,779,000 | |
| 15,518,000 | |
| 13,342,000 | |
| 14,587,000 | |
| 16,145,000 | |
| 20,855,000 | |
| 28,532,000 | |
| 33,143,000 | |
| 37,991,000 | |
| 39,346,000 | |
| 35,504,000 | |
| 31,789,000 | |
| 26,692,000 | |
| 21,896,000 | |
| 18,617,000 | |
| 14,170,000 | |
| 10,589,827 | |
| 7,458,822 | |
| 4,649,451 | |
| 4,021,200 | |
| 3,042,516 | |
| 2,926,309 | |
| 2,583,308 | |
| 3,041,726 | |
| 2,383,583 | |
| 1,555,795 | |
| 1,158,167 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |